- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07294313
Att utnyttja artificiell intelligens för att diagnostisera androgenetisk alopeci: En tränings- och valideringsstudie.
Att utnyttja artificiell intelligens för diagnostik av androgenetisk alopeci: En tränings- och valideringsstudie.
The aim of this study is to develop and validate deep learning models in diagnosis of male and female pattern hair loss, and assessment of its severity based on clinical and trichoscopic image by handheld dermoscopy and administrative data (age and sex).
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
The investigators intend to develop and validate artificial intelligence (AI) and machine learning (ML) models in diagnosis of male and female pattern hair loss, and assessment of its severity based on clinical and trichoscopic image using widely available and accessible handheld dermoscopes.
Conventional androgenetic alopecia (AGA) diagnosis and severity assessment are tedious and time-consuming tasks that are prone to human errors. These challenges can be tackled using artificial intelligence (AI), namely leveraging applications of machine learning and artificial neural networks for enhancing the diagnostic accuracy of scalp disease classification systems via dermoscopic image analysis. Computer aided assessment of hair microphotographs was attempted for decades, yet it faced many technical hurdles before the onset of deep learning and neural networks; and currently available software generate inaccurate results compared with visual counting. More accurate methods of analysis are needed for trichoscopic imaging, utilising deep learning image recognition models trained with a large image dataset. A number of deep learning models have been developed in recent years using videodermoscopy that achieved reliable hair density, thickness and severity classification, yet remain limited by small non-inclusive training datasets, need for hair shaving and lack of detailed reporting. Moreover, to our knowledge all previous models depend on image acquisition from expensive standalone videodermoscopy devices that lack widespread availability, rather than handheld dermoscopes that are commonly available.
The study will enroll 400 participants (200 healthy controls and 200 AGA patients). Controls undergo history and trichoscopic exams to exclude hair disorders. Trichoscopic examination will be conducted using a handheld dermoscope (CuTechs DS175) with a specialized field spacer. Patients will be assessed for disease severity using gender-specific scales. Both groups will have standardized digital and trichoscopic images taken for analysis. Images will be used to manually count and classify hairs, assess follicle units, and identify dermoscopic signs. A structured database will store all data and link clinical and image data to support objective diagnosis. AI models, particularly CNNs using transfer learning, will be trained on preprocessed images for classification and severity scoring. Model performance will be evaluated using metrics like accuracy, precision, recall, F1-score, and AUC-ROC compared with metrics reported by expert trichologists to validate accuracy and reliability
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Ahmed Mourad, MD
- Telefonnummer: 00201021534245
- E-post: ahmedmourad@kasralainy.edu.eg
Studera Kontakt Backup
- Namn: Noura Nour, MSc, MBBCh
- Telefonnummer: 00201271451744
- E-post: nouraadel41929@postgrad.kasralainy.edu.eg
Studieorter
-
-
Cairo Governorate
-
Cairo, Cairo Governorate, Egypten, 11553
- Rekrytering
- Faculty of Medicine Cairo University
-
Kontakt:
- Noura Nour, MSc, MBBch
- Telefonnummer: 00201271451744
- E-post: nouraadel41929@postgrad.kasralainy.edu.eg
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Patients diagnosed clinically and trichoscopically with androgenetic alopecia of both genders and apparently healthy controls.
Beskrivning
for the patient group:
Inclusion criteria:
- Patients with male or female pattern hair loss diagnosed clinically or suspected clinically and confirmed trichoscopically
- Age of disease onset 12-50 years old
- Both genders
- Any grade of androgenetic alopecia
- Any duration of androgenetic alopecia
- Any skin type
Exclusion criteria by clinical and trichoscopic examination:
- Patients with patchy hair loss or Telogen effluvium only.
- Patients with cicatricial alopecia or diffuse alopecia areata
- Patients with inflammatory scalp disorders (psoriasis, seborrheic dermatitis, lichen planopilaris and frontal fibrosing alopecia in a pattern distribution)
- Lack of patient cooperation.
for the control group: apparently healthy participants not suffering from the following: AGA, patchy hair loss, cicatricial alopecia, diffuse alopecia areata, inflammatory scalp disorders (psoriasis, seborrheic dermatitis, lichen planopilaris and frontal fibrosing alopecia in a pattern distribution).
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: CASE_CONTROL
- Tidsperspektiv: PROSPECTIVE
Kohorter och interventioner
Grupp / Kohort |
|---|
|
androgenetic alopecia
Patients diagnosed clinically and trichoscopically with androgenetic alopecia of both genders. The diagnosis of AGA requires fulfillment of the primary criterion, plus one or more of the secondary criteria, and absence of exclusion criteria:
|
|
normal controls
apparently normal participants not suffering from the following :
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
assessment of diagnostic capability of AI in AGA
Tidsram: 6 months
|
Assess accuracy, sensitivity, specificity and positive predictive value of the trained AI models in differentiating AGA affected from non-AGA affected subjects using their macroscopic and trichoscopic images. |
6 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
assessment of severity of androgenetic alopecia using AI
Tidsram: 6 months
|
Assess accuracy, sensitivity, specificity and positive predictive value of the trained AI models in assessment of severity of androgenetic alopecia as regards:
|
6 months
|
|
facilitation of AI assessment using macroscopic imagies
Tidsram: 6 months
|
To compare the model's diagnostic accuracy using the macroscopic versus trichoscopic images alone |
6 months
|
Samarbetspartners och utredare
Sponsor
Publikationer och användbara länkar
Allmänna publikationer
- Sacha JP, Caterino TL, Fisher BK, Carr GJ, Youngquist RS, D'Alessandro BM, Melione A, Canfield D, Bergfeld WF, Piliang MP, Kainkaryam R, Davis MG. Development and qualification of a machine learning algorithm for automated hair counting. Int J Cosmet Sci. 2021 Nov;43 Suppl 1:S34-S41. doi: 10.1111/ics.12735.
- Wang Y, Ding W, Yao M, Li Y, Wang M, Wang L, Li Z, Sun S, Yang M, Zhu Y, Zhou N. Diagnostic and grading criteria for androgenetic alopecia using dermoscopy. Skin Res Technol. 2024 Apr;30(4):e13649. doi: 10.1111/srt.13649.
- Kuczara A, Waskiel-Burnat A, Rakowska A, Olszewska M, Rudnicka L. Trichoscopy of Androgenetic Alopecia: A Systematic Review. J Clin Med. 2024 Mar 28;13(7):1962. doi: 10.3390/jcm13071962.
- Young AT, Xiong M, Pfau J, Keiser MJ, Wei ML. Artificial Intelligence in Dermatology: A Primer. J Invest Dermatol. 2020 Aug;140(8):1504-1512. doi: 10.1016/j.jid.2020.02.026. Epub 2020 Mar 27.
- Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Androgenetic Alopecia: Therapy Update. Drugs. 2023 Jun;83(8):701-715. doi: 10.1007/s40265-023-01880-x. Epub 2023 May 11.
- Bokhari L, Cottle P, Grimalt R, Kasprzak M, Sicinska J, Sinclair R, Tosti A. Efficiency of Hair Detection in Hair-to-Hair Matched Trichoscopy. Skin Appendage Disord. 2022 Sep;8(5):382-388. doi: 10.1159/000524345. Epub 2022 May 12.
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- MD-192-2025
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
relevant praticipant data shall be provided to researchers who request them on reasonable basis
Tidsram för IPD-delning
from 2027 indefintely
Kriterier för IPD Sharing Access
access will be provided to deidentified data including all study parameters
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- SAV
- ICF
- ANALYTIC_CODE
- CSR
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .